The percentage of CD11b+ cells of 4T1 tumor bearing mice due to advanced cancer-related myeloid expansion represented around 97% (Figure 7E) in contrast to naive mice with 35% CD11b+ cells (Figure 7D) of CD45+ living singlets in the blood. Here, ITGAM is linked to neoplasm.